Transfusion of allogenic leukocyte-depleted packed red blood cells is associated with postoperative morbidity in patients undergoing oral and oropharyngeal cancer surgery

Oral Oncology

Volumn 48, Issue 4, 2012, Pages 372-378

  Perisanidis, Christos ^a   Dettke, Markus ^a   Papadogeorgakis, Nikolaos ^b   Schoppmann, Alexandra ^a   Mittlböck, Martina ^a   Kyzas, Panayiotis A ^c   Ewers, Rolf ^a   Seemann, Rudolf ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF ATHENS   (Greece)

^c NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

Blood transfusion; Leucodepletion; Oral and oropharyngeal cancer; Postoperative morbidity

Indexed keywords

FLUOROURACIL; HEMOGLOBIN; MITOMYCIN C;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CANCER SURGERY; CARDIOVASCULAR DISEASE; CHEMORADIOTHERAPY; COMORBIDITY; DISEASE SEVERITY; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; FEMALE; FREE TISSUE GRAFT; GASTROINTESTINAL DISEASE; HEMATOMA; HUMAN; LENGTH OF STAY; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MOUTH CARCINOMA; MULTIPLE ORGAN FAILURE; NECK DISSECTION; NEUROLOGIC DISEASE; OROPHARYNX CARCINOMA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SCORING SYSTEM; SQUAMOUS CELL CARCINOMA; URINARY TRACT DISEASE; WOUND DEHISCENCE; WOUND INFECTION;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MORBIDITY; MOUTH NEOPLASMS; OROPHARYNGEAL NEOPLASMS; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84859441111     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2011.11.020     Document Type: Article

References (37)

1. Vamvakas EC, Blajchman MA. Deleterious clinical effects of transfusionassociated immunomodulation: fact or fiction? Blood 2001;97(5):1180-95. (Pubitemid 32183738)
2. Opelz G, Sengar DP, Mickey MR, Terasaki PI. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973;5(1):253-9.
3. Blajchman MA. Allogeneic blood transfusions, immunomodulation, and postoperative bacterial infection: do we have the answers yet? Transfusion 1997;37(2):121-5.
4. Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (TRIM): an update. Blood Rev 2007;21(6):327-48. (Pubitemid 47498679)
5. Bordin JO, Heddle NM, Blajchman MA. Biologic effects of leukocytes present in transfused cellular blood products. Blood 1994;84(6):1703-21. (Pubitemid 24286118)
6. Blajchman MA, Dzik S, Vamvakas EC, Sweeney J, Snyder EL. Clinical and molecular basis of transfusion-induced immunomodulation: summary of the proceedings of a state-of-the-art conference. Transfus Med Rev 2001;15(2):108-35. (Pubitemid 32303575)
7. Vamvakas EC, Blajchman MA. Universal WBC reduction: the case for and against. Transfusion 2001;41(5):691-712. (Pubitemid 32845014)
8. Fergusson D, Khanna MP, Tinmouth A, Hebert PC. Transfusion of leukoreduced red blood cells may decrease postoperative infections: two meta-analyses of randomized controlled trials. Can J Anaesth 2004;51(5):417-24.
9. Blumberg N, Zhao H, Wang H, Messing S, Heal JM, Lyman GH. The intention-totreat principle in clinical trials and meta-analyses of leukoreduced blood transfusions in surgical patients. Transfusion 2007;47(4):573-81. (Pubitemid 46449617)
10. Vamvakas EC. White-blood-cell-containing allogeneic blood transfusion and postoperative infection or mortality: an updated meta-analysis. Vox Sang 2007;92(3):224-32. (Pubitemid 46365029)
11. Sanabria A, Carvalho AL, Melo RL, Magrin J, Ikeda MK, Vartanian JG, et al. Predictive factors for complications in elderly patients who underwent head and neck oncologic surgery. Head Neck 2008;30(2):170-7. (Pubitemid 351251699)
12. Kao HK, Chang KP, Ching WC, Tsao CK, Cheng MH, Wei FC. Postoperative morbidity and mortality of head and neck cancers in patients with liver cirrhosis undergoing surgical resection followed by microsurgical free tissue transfer. Ann Surg Oncol 2010;17(2):536-43.
13. Robbins KT, Favrot S, Hanna D, Cole R. Risk of wound infection in patients with head and neck cancer. Head Neck 1990;12(2):143-8. (Pubitemid 20088323)
14. de Cassia Braga Ribeiro K, Kowalski LP, Latorre Mdo R. Perioperative complications, comorbidities, and survival in oral or oropharyngeal cancer. Arch Otolaryngol Head Neck Surg 2003;129(2):219-28. (Pubitemid 36222572)
15. Liu SA, Wong YK, Poon CK, Wang CC, Wang CP, Tung KC. Risk factors for wound infection after surgery in primary oral cavity cancer patients. Laryngoscope 2007;117(1):166-71.
16. Farwell DG, Reilly DF, Weymuller Jr EA, Greenberg DL, Staiger TO, Futran NA. Predictors of perioperative complications in head and neck patients. Arch Otolaryngol Head Neck Surg 2002;128(5):505-11. (Pubitemid 34493717)
17. Cloke DJ, Green JE, Khan AL, Hodgkinson PD, McLean NR. Factors influencing the development of wound infection following free-flap reconstruction for intraoral cancer. Br J Plast Surg 2004;57(6):556-60. (Pubitemid 39145158)
18. Lotfi CJ, Cavalcanti Rde C, Costa e Silva AM, Latorre Mdo R, Ribeiro Kde C, Carvalho AL, et al. Risk factors for surgical-site infections in head and neck cancer surgery. Otolaryngol Head Neck Surg 2008;138(1):74-80. (Pubitemid 350299639)
19. Vamvakas EC, Blajchman MA. Prestorage versus poststorage white cell reduction for the prevention of the deleterious immunomodulatory effects of allogeneic blood transfusion. Transfus Med Rev 2000;14(1):23-33. (Pubitemid 30057081)
20. Sobin LH, Wittekind C. TNM classification of malignant tumors. 6th ed. London: Wiley; 2002.
21. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40(5):373-83. (Pubitemid 17055592)
22. Bhide SA, Ahmed M, Rengarajan V, Powell C, Miah A, Newbold K, et al. Anemia during sequential induction chemotherapy and chemoradiation for head and neck cancer: the impact of blood transfusion on treatment outcome. Int J Radiat Oncol Biol Phys 2009;73(2):391-8.
23. Fenner M, Vairaktaris E, Nkenke E, Weisbach V, Neukam FW, Radespiel-Troger M. Prognostic impact of blood transfusion in patients undergoing primary surgery and free-flap reconstruction for oral squamous cell carcinoma. Cancer 2009;115(7):1481-8.
24. Klug C, Berzaczy D, Voracek M, Enislidis G, Rath T, Millesi W, et al. Experience with microvascular free flaps in preoperatively irradiated tissue of the oral cavity and oropharynx in 303 patients. Oral Oncol 2005;41(7):738-46. (Pubitemid 40981115)
25. Freier K, Engel M, Lindel K, Flechtenmacher C, Muhling J, Hassfeld S, et al. Neoadjuvant concurrent radiochemotherapy followed by surgery in advanced oral squamous cell carcinoma (OSCC): a retrospective analysis of 207 patients. Oral Oncol 2008;44(2):116-23. (Pubitemid 351179655)
26. Eich HT, Loschcke M, Scheer M, Kocher M, Bongartz R, Wacker S, et al. Neoadjuvant radiochemotherapy and radical resection for advanced squamous cell carcinoma of the oral cavity. Outcome of 134 patients. Strahlenther Onkol 2008;184(1):23-9.
27. Eckardt A, Sinikovic B, Hofele C, Bremer M, Reuter C. Preoperative paclitaxel/ carboplatin radiochemotherapy for stage III/IV resectable oral and oropharyngeal cancer: seven-year follow-up of a phase II trial. Oncology 2007;73(3-4):198-203. (Pubitemid 351630050)
28. Driemel O, Ettl T, Kolbl O, Reichert TE, Dresp BV, Reuther J, et al. Outcome and histopathologic regression in oral squamous cell carcinoma after preoperative radiochemotherapy. Strahlenther Onkol 2009;185(5):296-302.
29. Perioperative red blood cell transfusion. JAMA 1988;260(18):2700-03
30. Dindo D, Clavien PA. What is a surgical complication? World J Surg 2008;32(6):939-41.
31. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240(2):205-13. (Pubitemid 38963009)
32. Perisanidis C, Herberger B, Papadogeorgakis N, Seemann R, Eder-Czembirek C, Tamandl D, et al. Complications after free flap surgery: do we need a standardized classification of surgical complications? Br J Oral Maxillofac Surg 2011;100:10-20.
33. Johnson JT, Myers EN, Thearle PB, Sigler BA, Schramm VL, Jr. Antimicrobial prophylaxis for contaminated head and neck surgery. Laryngoscope 1984;94(1):46-51. (Pubitemid 14224104)
34. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 2006;105(1):198-208.
35. Marik PE, Corwin HL. Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crit Care Med 2008;36(9): 2667-74.
36. Murphy MF, Wallington TB, Kelsey P, Boulton F, Bruce M, Cohen H, et al. Guidelines for the clinical use of red cell transfusions. Br J Haematol 2001;113(1):24-31. (Pubitemid 32423296)
37. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999;340(6):409-17. (Pubitemid 29084771)